Aprea Therapeutics, Inc. - Common Stock, $0.001 par value per share (APRE)

Q: What does CUSIP 03836J102 represent in this 13F holders report?

CUSIP 03836J102 is the security identifier for APRE - Aprea Therapeutics, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

Q: How many institutions held APRE - Aprea Therapeutics, Inc. - Common Stock, $0.001 par value per share in Q4 2024?

No institutional holders were reported for APRE - Aprea Therapeutics, Inc. - Common Stock, $0.001 par value per share in Q4 2024; review adjacent reporting periods for trend context.

CUSIP: 03836J102

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 6,583,303
Total 13F shares: 0
Share change: -899
Total reported value: $0
Number of holders: 0
Value change: -$2,000
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 03836J102?
CUSIP 03836J102 identifies APRE - Aprea Therapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q3 2024

Recent filing periods for CUSIP 03836J102:

Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023

Aprea Therapeutics, Inc. - Common Stock, $0.001 par value per share (APRE)

Q4 2024 13F Holders as of 31 Dec 2024

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of APRE - Aprea Therapeutics, Inc. - Common Stock, $0.001 par value per share as of Q4 2024.